Infectious Diseases Market Research Report, Growth & Forecast

The global Drugs for Herpes Labialis (Oral Herpes) market size is expected to reach $ 4013 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032). Herpes Labial...

The global Drugs for Malaria market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032). Drugs for malaria or antimalarial medication...

The global Hospital-Acquired Pneumonia Prevention market size is expected to reach $ 298 million by 2032, rising at a market growth of 6.4% CAGR during the forecast period (2026-2032). Dental plaque i...

The Dengue – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers i...

Monkeypox Market reached US$ 93.17 million in 2023 and is expected to reach US$ 264 million by 2031, growing with a CAGR of 10.16% during the forecast period 2026-2031. The Monkeypox Market emerges as...

The Global Chikungunya Fever Market, valued at USD 493.23 Million in 2024, is projected to experience a CAGR of 7.28% to reach USD 751.91 Million by 2030. The Global Chikungunya Fever Market encompass...

The Global Perinatal Infections Market, valued at USD 1.60 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 2.18 Billion by 2030. The Global Perinatal Infections Market focuses...

According to our latest research, the global AI-based Malaria Solution market size will reach USD 686 million in 2031, growing at a CAGR of 7.9% over the analysis period. AI-based Malaria Solution ref...

Global HIV Therapeutics Market reached US$ 37.61 Billion in 2024 and is expected to reach US$ 57.56 Billion by 2033, growing with a CAGR of 4.80% during the forecast period 2026-2033. The Global HIV T...

Global Respiratory Syncytial Virus (RSV) Market reached US$ 1.95 billion in 2024 and is expected to reach US$ 4.54 billion by 2033, growing with a CAGR of 9.90% during the forecast period 2026-2033. T...

According to Stratistics MRC, the Global Infectious Disease Management Market is accounted for $23.3 billion in 2025 and is expected to reach $38.9 billion by 2032 growing at a CAGR of 7.6% during the...

The Sexually Transmitted Infections (Stis) Market is valued at USD 61.4 billion in 2025 and is projected to grow at a CAGR of 13.7% to reach USD 194.5 billion by 2034.The global sexually transmitted i...

The global Cerebral Malaria Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the lat...

According to this study, the global Ebola Treatment market size will reach US$ million by 2031. Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called...

The global C Difficile Infection Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...

The global Klebsiella Pneumoniae Infection Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of...

The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The...

The global Candidiasis Therapeutics market size is predicted to grow from US$ 3222 million in 2025 to US$ 3920 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031. The impact o...

The global Chagas Disease Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. t...

According to this study, the global Hepatitis C Drugs market size will reach US$ million by 2031. Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-l...

The global necrotizing fasciitis market size was estimated at USD 1,027.24 million in 2024 and is projected to reach USD 2,097.81 million by 2033, growing at a CAGR of 8.3% from 2025 to 2033. The mark...

Infectious Diseases Treatment Market Size & Industry Outlook The global infectious diseases treatment market size reached US$ 189.09 Billion in 2024 from US$ 182.65 Billion in 2023 and is expected to...

Valley Fever Market Size & Industry Outlook The global valley fever market size reached US$ 1.03 Billion with rise of US$ 1.10 Billion in 2024 is expected to reach US$ 1.98 Billion by 2033, growing at...

The global Bedaquiline Fumarate Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market f...

Epstein-barr virus (EBV) is a common virus that belongs tthe herpesvirus family, with over 90% of the global population being infected at some point in their lives. EBV is primarily spread through sal...

The Influenza A – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report deliv...

The Tuberculosis – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report deli...

Valley Fever Market reached US$ 1.10 Billion in 2024 and is expected to reach US$ 1.98 Billion by 2033, growing with a CAGR of 6.80% during the forecast period 2026-2033. The Valley Fever Market emerg...

Neglected Tropical Disease Treatment Market The global neglected tropical disease treatment market size was estimated at USD 3.96 billion in 2024 and is projected to reach USD 6.04 billion by 2033, gr...

Global Avian Influenza Treatment Market reached US$ 11.38 billion in 2023 and is expected to reach US$ 28.22 billion by 2033, growing with a CAGR of 9.60% during the forecast period 2026-2033. The Glo...

The Pseudomonas Aeruginosa Infection Treatment Market size is valued at USD 3.2 billion in 2025 and is projected to reach USD 5.7 billion by 2033, registering a compound annual growth rate (CAGR) of 7...

The Oropouche Fever Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...

... INCLUDES: 84 data tables and 23 additional tables An overview of the global market for infectious disease treatments, with a focus on the growth in demand for newer pharmaceutical ...

According to Stratistics MRC, the Global Encephalitis Treatment Market is accounted for $23.9 billion in 2025 and is expected to reach $38.9 billion by 2032 growing at a CAGR of 7.2% during the foreca...

Hepatitis B Treatment Market reached US$ 3.57 billion in 2024 and is expected to reach US$ 6.47 billion by 2033, growing with a CAGR of 6.90% during the forecast period 2026-2033. The Hepatitis B Trea...

The global HIV drugs market size was valued at USD 32.85 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 45.07 Billion by 2033, exhibiting a CAGR of 3.40% during 2025-2...

According to Stratistics MRC, the Global Infectious Disease Therapeutics Market is accounted for $135.25 billion in 2025 and is expected to reach $206.49 billion by 2032 growing at a CAGR of 6.23% dur...

Aspergillosis Market reached US$ 3.2 billion in 2022 and is expected to reach US$ 6.5 billion by 2031, growing with a CAGR of 5.60% during the forecast period 2026-2031. The Aspergillosis Market emerg...

The Bacterial (Pyogenic) Meningitis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...

North America Hepatitis B Treatment Market reached US$ 1.66 billion in 2024 and is expected to reach US$ 3.01 billion by 2033, growing with a CAGR of 6.90% during the forecast period 2026-2033. The No...

According to Stratistics MRC, the Global Anti-Malarial Drugs Market is accounted for $1044.1 million in 2024 and is expected to reach $1439.6 million by 2030 growing at a CAGR of 5.5% during the forec...

Botulism Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Botulism Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned resear...

The Acinetobacter Infections Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...

Pharyngitis Treatment Marketis is growing with a CAGR of 4.50% during the forecast period 2026-2035. The Pharyngitis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analy...

The Bacteremia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...

The Visceral Leishmaniasis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...

The Herpes Labialis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to delive...

Neglected Tropical Disease Treatment Marketis is growing with a CAGR of 5.20% during the forecast period 2026-2035. The Neglected Tropical Disease Treatment Market emerges as a key focus in DataM Inte...

Skin and Soft Tissue Infections Market reached US$ 11,283.71 million in 2023 and is expected to reach US$ 21,708.55 million by 2031, growing with a CAGR of 8.80% during the forecast period 2026-2031....

The Bubonic Plague Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalle...